News

(07 May 2021) - The European Commission is proposing a strategy on COVID-19 therapeutics to support the development and availability of COVID-19 therapeutics, including for the treatment of ‘long COVID'.

COVID-19
© Governor Tom Wolf/Flickr

The strategy covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.

The European Medicines Agency has today started the rolling review of sotrovimab (VIR-7831), a monoclonal antibody developed for the treatment of COVID-19.

The Commission will draw up a portfolio of 10 potential COVID-19 therapeutics and by June 2021, identify the five most promising ones.

New authorisations, rolling reviews and joint procurement contracts will be up and running before the end of the year.

More information

     
TOP